A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT05073315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind Study Evaluating the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Multiple Switches Between Humira® (Adalimumab [US]) and ABP 501 Compared With Continued Use of Adalimumab in Subjects With Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study to evaluate pharmacokinetics, efficacy, safety and immunogenicity of multiple switches between Humira® and ABP 501 (new high concentration formulation) compared with continued use of Humira® in participants with moderate to severe plaque psoriasis. This multi-center study is composed of two periods: A lead-in period of treatment with Humira® followed by a randomized two parallel arm period.
Study identification
- NCT ID
- NCT05073315
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 425 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2021 (Actual)
- Primary completion
- Dec 19, 2022 (Actual)
- Completion
- Dec 19, 2022 (Actual)
- Last update posted
- Feb 9, 2024
2021 – 2022
United States locations
- U.S. sites
- 35
- U.S. states
- 20
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center PC | Birmingham | Alabama | 35205 | — |
| Johnson Dermatology Clinic | Fort Smith | Arkansas | 72916 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Unison Clinical Trials | Sherman Oaks | California | 91403 | — |
| Revival Research | Doral | Florida | 33122 | — |
| Altus Research, Inc. | Lake Worth | Florida | 33461 | — |
| International Dermatology Research, Inc | Miami | Florida | 33144 | — |
| Tory Sullivan MD PA | North Miami Beach | Florida | 33162-4708 | — |
| Marietta dermatology skin care | Marietta | Georgia | 30060 | — |
| Georgia Skin and Cancer Clinic - Clinic | Savannah | Georgia | 31419 | — |
| NorthShore University HealthSystem Dermatology | Skokie | Illinois | 60077 | — |
| Deaconess Clinic Downtown | Evansville | Indiana | 47708 | — |
| Lawrence J Green, MD, LLC | Rockville | Maryland | 20850 | — |
| ALLCUTIS Research, LLC. | Beverly | Massachusetts | 01915 | — |
| Metro Boston Clinical Partners | Brighton | Massachusetts | 02135 | — |
| David Fivenson, MD, PLC | Ann Arbor | Michigan | 48103 | — |
| Henry Ford Health System - New Center One | Detroit | Michigan | 48202 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| Vivida Dermatology | Las Vegas | Nevada | 89119 | — |
| Skin Search of Rochester, Inc. | Rochester | New York | 14623 | — |
| Wilmington Dermatology Center | Wilmington | North Carolina | 28405 | — |
| Wright State Physicians, Inc | Fairborn | Ohio | 45324 | — |
| Dermatologists of Southwest Ohio | Mason | Ohio | 45040 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| University of Pittsburgh Medical Center/Falk Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Clinical Research Center of the Carolinas | Charleston | South Carolina | 29407 | — |
| International Clinical Research - Tennessee LLC | Murfreesboro | Tennessee | 37130 | — |
| Bellaire Dermatology Associates (BDA) | Bellaire | Texas | 77401-3505 | — |
| Center for Clinical Studies, LTD.LLP | Houston | Texas | 77004 | — |
| Austin Institute for Clinical Research - Dermatology | Houston | Texas | 77056 | — |
| Cutis Wellness Dermatology & Dermapathology, PLLC | Laredo | Texas | 78041 | — |
| Progressive Clinical Research [Texas] | San Antonio | Texas | 78213 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05073315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05073315 live on ClinicalTrials.gov.